SBFMW
Sunshine Biopharma Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-2.21
Beta
1.60
52W High
$0.45
52W Low
$0.05
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-16.50%
Forward P/E
—
PEG Ratio
—
About Sunshine Biopharma Inc. Warrant
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.
Fundamentals
| Revenue (TTM) | $36.31M |
| Gross Profit (TTM) | $12.26M |
| EBITDA | $-4.15M |
| Operating Margin | -19.30% |
| Return on Equity | -25.70% |
| Return on Assets | -9.23% |
| Revenue/Share (TTM) | $8.73 |
| Book Value | $4.69 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -10.60% |
| Shares Outstanding | 0 |
| Float | $4.90M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/16/2026